Results 141 to 150 of about 6,736 (217)

Preparing Adjuvanted Nanoliposomes for Applications Toward Recombinant Influenza Vaccine Development. [PDF]

Bio Protoc
Sia ZR, Huang WC, Willadsen M, Kutscher HL, Lovell JF, Davidson BA.   +5 more
europepmc   +1 more source

A Naked Lyophilized mRNA Vaccine Against Seasonal Influenza, Administered by Jet Injection, Provides a Robust Response in Immunized Mice. [PDF]

Vaccines (Basel)
Sharabrin SV, Krasnikova SI, Kisakov DN, Borgoyakova MB, Yakovlev VA, Tigeeva EV, Starostina EV, Litvinova VR, Kisakova LA, Vahitov DI, Makarova KP, Volosnikova EA, Ivanova KI, Bondar AA, Rudometova NB, Rudometov AP, Ilyichev AA, Karpenko LI.   +17 more
europepmc   +1 more source

Glycoproteomic and Single-Protein Glycomic Analyses Reveal Zwitterionic N-Glycans on Natural and Recombinant Proteins Derived From Insect Cells. [PDF]

Mol Cell Proteomics
Yan S, Vanbeselaere J, Ives C, Stenitzer D, Nuschy L, Wöls F, Paschinger K, Fadda E, Stadlmann J, Wilson IBH.   +9 more
europepmc   +1 more source

Inverted H1 hemagglutinin nanoparticle vaccines protect mice against challenges with human H1N1 and bovine H5N1 influenza viruses. [PDF]

NPJ Vaccines
Biswas A, Loeffler K, Kim D, Eisfeld AJ, Duffy A, Hammond H, Sangappa A, Abozeid HH, Neumann G, Moreno A, Kawaoka Y, Kane RS.   +11 more
europepmc   +1 more source

Panzootic H5 influenza viruses acquired resistance to human head interface antibodies. [PDF]

PLoS Pathog
Graber AL, Simmons HC, McCarthy KR.
europepmc   +1 more source

Deoxyshikonin Inhibits Influenza A Virus Infection at an Early Stage. [PDF]

Int J Mol Sci
Cho WK, Ma JY.
europepmc   +1 more source

The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibody. [PDF]

Structure
Rawi R, Morano NC, Cheung CS, Du H, Gorman J, Prabhakaran M, Becker JE, Bylund T, Charaf S, Chen X, Lee M, Harris DR, Olia AS, Ou L, Wang L, Wang S, Zhang B, Kanekiyo M, McDermott AB, Zhou T, Shapiro L, Kwong PD.   +21 more
europepmc   +1 more source

Lemierre's Syndrome: A Rare but Resurging Disease. [PDF]

Cureus
Subramonian A, Bdiri H, Bajwa D, Fong C, Momoh R.   +4 more
europepmc   +1 more source

Chronology of H3N2 human influenza virus surface glycoprotein adaptation from 1968 to 2019 reveals a surge of adaptation between 1997 and 2002. [PDF]

J Virol
Lei H, Xiao B, Lin X, Liang Z, Ling S, Bai Y, Dhanasekaran V, Song W, Wong S-S, Zanin M.   +9 more
europepmc   +1 more source

On the brink of emergence: an evolutionary approach to Influenza A virus H5N1 isolated from humans. [PDF]

Virus Res
Ferreiro I, Hurtado J, Bruno A, Cristina J.   +3 more
europepmc   +1 more source